首页 | 官方网站   微博 | 高级检索  
     


Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice
Affiliation:1. Inserm U669, Maison des Adolescents, Hôpital Cochin, AP–HP, 75679 Paris France;2. Université Paris Descartes, 75006 Paris, France;3. Department of Cardiology, Hôpital Cochin, AP–HP, 75014 Paris, France;4. FA-7334 Internal Medicine, Hôpital Louis-Mourier, Université Paris 7, AP–HP, 92700 Colombes, France;5. Geriatrics Department, Hôpital Broca, AP–HP, 75013 Paris, France;6. Normandie Université, UNICAEN, Inserm U1237, CHU Caen, 14000 Caen, France;7. Department of Cardiology, Hôpital Européen Georges-Pompidou, AP–HP, 75015 Paris, France;8. ICTA, 21121 Fontaine-lès-Dijon, France;9. Bristol-Myers Squibb, 92506 Rueil-Malmaison, France;10. Department of Cardiology, Hôpital Bichat, AP–HP, 75018 Paris, France;11. Inserm U1148, Université Paris Diderot, 75877 Paris, France
Abstract:
Keywords:Anticoagulation  Atrial fibrillation  Non-vitamin K antagonist oral anticoagulants  Observational study  Vitamin K antagonists  Anticoagulation  Fibrillation auriculaire  Anticoagulants directs oraux  Étude observationnelle  Antivitamine K  AF"}  {"#name":"keyword"  "$":{"id":"kw0060"}  "$$":[{"#name":"text"  "_":"atrial fibrillation  CI"}  {"#name":"keyword"  "$":{"id":"kw0070"}  "$$":[{"#name":"text"  "_":"confidence interval  NOAC"}  {"#name":"keyword"  "$":{"id":"kw0080"}  "$$":[{"#name":"text"  "_":"non-vitamin K antagonist oral anticoagulant  NVAF"}  {"#name":"keyword"  "$":{"id":"kw0090"}  "$$":[{"#name":"text"  "_":"non-valvular atrial fibrillation  SmPC"}  {"#name":"keyword"  "$":{"id":"kw0100"}  "$$":[{"#name":"text"  "_":"summary of product characteristics  VKA"}  {"#name":"keyword"  "$":{"id":"kw0110"}  "$$":[{"#name":"text"  "_":"vitamin K antagonist
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号